About Recursion
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Latest Quarterly Earnings
Q3
2024
Press Releases
Dec 20, 2024
Dec 09, 2024
Events
Dec 11, 2024 at 10:00 AM EST
Nov 20, 2024 at 1:00 PM GMT
Jun 10, 2024 at 12:00 PM EDT
Environmental, Social & Governance
ESG stewardship is both an integral part of our mission and essential to achieving it. We are proud of the progress we have made and are committed to further advancing our capabilities in the years to come.